Screener / SEC EDGAR /CIK 0001756262 /10-K filed Feb 24, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Devices

TransMedics Group, Inc. TMDX

Compare with peers Embed
Planned sales, announced before they happen

2 trading plans running, 7 Form 144 notices for $4.0M

10-Q, 10-K and Form 144

What TMDX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 6, 2024 to Feb 2, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Edward Basile
Adopted 10b5-1 plan Mar 4, 2026 10-Q May 5, 2026
Tamer Khayal
Adopted 10b5-1 plan Dec 11, 2025 10-K Feb 24, 2026
James R. Tobin 2012 Trust
Adopted 10b5-1 plan Sep 3, 2025 10-Q Oct 29, 2025
Tamer Khayal
Adopted 10b5-1 plan Dec 5, 2024 10-K Feb 27, 2025
Edward Basile
Adopted 10b5-1 plan Nov 6, 2024 10-K Feb 27, 2025
Edward Basile
Director
Adopted 10b5-1 plan – 10-Q Nov 8, 2023
James R. Tobin
2012 Trust
Adopted 10b5-1 plan – 10-Q Oct 29, 2024
Stephen Gordon
Chief Financial Officer
Adopted 10b5-1 plan – 10-Q Oct 29, 2024
Stephen Gordon
Chief Financial Officer
Adopted 10b5-1 plan – 10-Q Nov 8, 2023
Tamer Khayal
Chief Commercial Officer
Adopted 10b5-1 plan – 10-Q Nov 8, 2023
Waleed Hassanein
M.D., Chief Executive Officer
Adopted 10b5-1 plan – 10-Q Nov 8, 2023
Show the other 3 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 9, 2026 JAMES R. TOBIN
Director
4,059 $385K
Jun 15, 2026 THOMAS GUNDERSON
Director
9,624 $722K
Mar 4, 2026 GERARDO P HERNANDEZ
Officer
7,236 $1.1M
Mar 4, 2026 STEPHANIE LOVELL
Director
1,193 $178K
Mar 4, 2026 DAVID WEILL
Director
3,571 $524K
Dec 3, 2025 DAVID WEILL
Director
5,000 $693K
Nov 25, 2025 ANIL P RANGANATH
Officer
3,000 $436K

From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TMDX/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.